Relapses and progression of disability in multiple sclerosis

Area of Science:

• Neurology
• Neuroimmunology
• Clinical Epidemiology

Background:

• The relationship between multiple sclerosis (MS) onset patterns, disease relapses, and the development of irreversible disability remains a subject of debate.
• Understanding these factors is crucial for predicting disease trajectory and managing patient care in multiple sclerosis.

Purpose of the Study:

• To investigate the influence of multiple sclerosis (MS) onset patterns and relapses on the time course of irreversible disability.
• To analyze the impact of relapsing-remitting versus progressive disease courses on disability progression.

Main Methods:

• Longitudinal study of 1844 patients with multiple sclerosis, followed for a mean of 11 years.
• Assessment of disease onset (relapsing-remitting vs. progressive), relapse frequency, and time to irreversible disability using Kurtzke Disability Status Scale scores (4, 6, and 7).
• Kaplan-Meier analyses were employed to evaluate the association between relapses and disability progression.

Main Results:

• Patients with a relapsing-remitting onset had significantly longer times to reach disability scores of 4, 6, and 7 compared to those with a progressive onset (P<0.001).
• The time taken to progress from disability score 4 to 6 was similar between relapsing-remitting and progressive onset groups (P=0.74).
• In primary progressive multiple sclerosis, superimposed relapses did not alter the progression of irreversible disability.

Conclusions:

• Relapses do not appear to significantly influence the progression of irreversible disability in patients with multiple sclerosis.
• The initial disease course (relapsing-remitting vs. progressive) is a more significant determinant of the time to irreversible disability than the occurrence of relapses.